Stem cells are unspecialized cells that can develop into any type of cell in the body. This makes them a promising tool for regenerative medicine, but researchers have yet to fully understand how they make decisions about which type of cell to become.
The new study, published in the journal Nature, shows that stem cells use a process called "chromatin remodeling" to choose their fate. Chromatin is the material that makes up chromosomes, and it contains the instructions for building proteins. By remodeling the chromatin, stem cells can change which genes are expressed, and this in turn determines which type of cell they become.
The researchers found that stem cells use a specific protein called SWI/SNF to remodel the chromatin. SWI/SNF is a member of the SWI/SNF family of proteins, which are known to play a role in gene expression.
When the researchers inhibited SWI/SNF, stem cells were unable to differentiate into specific cell types. This suggests that SWI/SNF is essential for stem cell differentiation.
The discovery of SWI/SNF's role in stem cell differentiation could lead to new treatments for a variety of diseases. For example, researchers could use SWI/SNF to differentiate stem cells into specific cell types that could then be used to repair damaged tissue. This approach could potentially be used to treat diseases such as heart disease, stroke, and spinal cord injury.
The study also provides new insights into the basic biology of stem cells. By understanding how stem cells make decisions about which type of cell to become, researchers can gain a better understanding of how the body develops and how diseases occur.
"This study is a major breakthrough in our understanding of stem cell differentiation," said study author Dr. Miguel Ramalho-Santos. "It opens up new possibilities for using stem cells to treat diseases and for understanding how the body develops."
